Aprogen

Aprogen is the first and only biopharmaceutical development company among South Korea's unicorn enterprises. Aprogen is primarily known for its development of Antibody Biosimilars, including therapeutic antibodies or proteins for autoimmune diseases, rheumatoid arthritis, breast cancer, lymphoma, and colorectal cancer. The company has also begun the research and development of new drugs. Its core technologies include: protein and antibody drug design technology, cell line cultivation technology for antibody drug production, large-scale drug production technology based on bioreactors, and pharmacodynamic and pharmacological property analysis technology.